Rate My Professor Gang Zheng

Dr. Gang Zheng serves as a Research Fellow and Pre-clinical MRI Physicist at Monash Biomedical Imaging, Monash University. He obtained his Bachelor’s degree in Science from Nanjing University of Aeronautics and Astronautics on December 31, 2002, and his Ph.D. in Biomedical Engineering from the same institution on December 31, 2007. After completing his doctorate, Dr. Zheng joined his alma mater as a Lecturer in 2008 and advanced to Associate Professor in 2014. In 2010, he began clinical research at the Department of Radiology, Jinling Hospital, Medical School of Nanjing University, focusing on hepatic encephalopathy using functional MRI under the supervision of Dr. Guangming Lu, Head of the MRI team of the Chinese Society of Radiology. Between 2013 and 2014, he conducted research at the Center for Functional Neuroimaging, University of Pennsylvania, supervised by Dr. Ze Wang, contributing to projects on arterial spin labelling MRI and brain connectome analysis. Currently, as a Monash University Facility Fellow with the National Imaging Facility, Dr. Zheng supports advanced preclinical imaging studies across various disciplines at Monash.

Dr. Zheng's research centers on developing noninvasive perfusion and metabolism functional MRI techniques. His interests include metabolic brain diseases such as hepatic encephalopathy, uremic encephalopathy, and brain disorders caused by systemic lupus erythematosus, as well as genetics-based early detection of Alzheimer’s disease risk. He has co-authored several impactful publications, including 'Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice' (Biomedicine & Pharmacotherapy, 2023), 'Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation' (American Journal of Physiology - Heart and Circulatory Physiology, 2024), 'Pharmacological inhibition of STING reduces neuroinflammation-mediated damage post-traumatic brain injury' (British Journal of Pharmacology, 2024), and 'Shared and specific patterns of interhemispheric functional connectivity in bipolar disorder and schizophrenia revealed by BOLD fMRI' (Cerebral Cortex, 2025). His expertise in MR physics facilitates preclinical research in neuroscience, cardiovascular physiology, and beyond, contributing to advancements in noninvasive imaging methodologies.